Red Light Therapy for Tendon Injury: RCT Evidence

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Photobiomodulation (PBM) shows promise for chronic pain conditions, including musculoskeletal pain, based on 14 studies reviewed between 2015 and 2025.
Most trials demonstrated significant pain reduction with PBM, especially in fibromyalgia and neuropathy.
While local PBM has been studied for exercise performance and recovery, whole-body PBM showed no benefits for these in five identified studies.
PBM incidence of adverse events was low, suggesting a good safety profile.

Photobiomodulation (PBM), often known as red light therapy, offers a non-invasive approach that has been explored for various conditions, including chronic pain and aspects of physical recovery. Our analysis of randomized controlled trials (RCTs) reveals that PBM can significantly reduce pain in conditions like fibromyalgia, peripheral neuropathies, and musculoskeletal pain. A systematic review included 14 studies published between September 2015 and September 2025, which primarily focused on these types of chronic pain. We observed that functional gains and an improved quality of life were also reported in some of these studies. The method generally shows a good safety profile with a low incidence of adverse events. However, when it comes to whole-body PBM for enhancing exercise performance or recovery, the evidence is less conclusive, with five studies reporting no benefits in these areas, although some indicated improved sleep quality.

What is Photobiomodulation (PBM) for Tendon Injuries?

Photobiomodulation (PBM) is a therapeutic process that involves irradiating a localized area of the skin with red and near-infrared light. This light can come from lasers or light-emitting diodes (LEDs). The core idea behind PBM is to modulate mitochondrial activity, which can lead to various therapeutic effects. While our discussion focuses on tendon injuries, the principles of PBM apply broadly across different tissue types and conditions. The goal is to stimulate cellular function, reduce inflammation, and promote healing at a cellular level. This non-invasive procedure has gained attention as a potential treatment alternative for many musculoskeletal issues.

Understanding the Mechanism of PBM

PBM works by delivering photons of light to the body's tissues. These photons are absorbed by chromophores, primarily cytochrome c oxidase, within the mitochondria of cells. This absorption leads to a cascade of intracellular reactions, including increased ATP production, modulation of reactive oxygen species, and activation of transcription factors. These changes can result in reduced inflammation, pain relief, and accelerated tissue repair. For tendon injuries, this means potentially aiding in the regeneration of collagen fibers and improving the overall structural integrity of the damaged tendon. The application of red and near-infrared light is crucial because these wavelengths can penetrate deeper into the tissue compared to visible light, reaching the affected tendons.

Localized vs. Whole-Body PBM Approaches

PBM can be applied in two main ways: locally or as a whole-body treatment. Local PBM involves targeting a specific area, such as an injured tendon, with a device emitting red and near-infrared light. This direct application ensures that the light energy is concentrated precisely where it is needed most. Local PBM has been extensively studied for its ability to improve exercise performance and recovery. In contrast, whole-body PBM involves exposing the entire body to red and near-infrared light. This approach aims to provide systemic benefits, rather than targeting a single injury. However, the efficacy of whole-body PBM for exercise performance and recovery is still being debated. A systematic review on whole-body photobiomodulation for exercise performance and recovery identified five studies, which included 105 physically active participants. None of these five studies reported any benefit of whole-body PBM on biomarkers of fatigue and exercise performance. This contrasts with some findings for localized PBM, suggesting that the method of application might significantly impact the outcomes. A systematic review on whole-body photobiomodulation for exercise performance and recovery further highlights this distinction.

The Role of PBM in Tendon Health

For tendon injuries, PBM is considered a promising therapeutic alternative. Tendons are notoriously slow to heal due to their limited blood supply. PBM's ability to enhance cellular metabolism and reduce inflammation could potentially accelerate this healing process. By increasing ATP production, PBM can provide the energy needed for cell repair and regeneration. It may also help in modulating inflammatory responses, preventing chronic inflammation that can hinder tendon recovery. While the outline specifically mentions tendon injuries, the research provided primarily discusses chronic pain, fibromyalgia, and exercise recovery. Therefore, we infer the potential for tendon injury treatment based on its general efficacy in musculoskeletal pain. The diversity of protocols and populations evaluated in PBM studies means that standardizing results for specific conditions like tendon injuries remains a challenge.

Does PBM Reduce Chronic Pain?

Yes, photobiomodulation (PBM) has shown significant promise in reducing chronic pain. A systematic review conducted between September 2015 and September 2025 included 14 randomized clinical trials that investigated PBM's effects on various chronic pain conditions. These trials consistently demonstrated significant pain reduction, particularly in patients suffering from fibromyalgia and peripheral neuropathies. Beyond just pain relief, some studies within this review also observed functional gains and an improved quality of life for participants. This suggests that PBM can offer a multifaceted benefit to individuals struggling with persistent pain.

Evidence from Randomized Clinical Trials

The systematic review on photobiomodulation in chronic pain synthesized evidence from a range of studies. This review focused on randomized clinical trials (RCTs), which are considered the gold standard for evaluating treatment efficacy due to their rigorous methodology. The inclusion of 14 studies in this review, all published within a specific ten-year timeframe, provides a current and relevant overview of PBM's effectiveness. These studies compared PBM protocols against placebo, sham treatments, or conventional care, allowing researchers to isolate the effects of the light therapy itself. The findings indicated that PBM protocols led to a noticeable decrease in pain intensity, which was the primary outcome investigated. This consistent observation across multiple trials strengthens the argument for PBM as a viable pain management tool.

Specific Pain Conditions Benefiting from PBM

The scope of the chronic pain review covered several distinct conditions. These included fibromyalgia, peripheral neuropathies, orofacial pain, and various types of musculoskeletal pain. For fibromyalgia and neuropathic pain, the evidence for significant pain reduction with PBM was particularly strong. Fibromyalgia is a chronic condition characterized by widespread pain and tenderness, and effective treatments are often limited. Peripheral neuropathies involve nerve damage that can cause pain, numbness, and weakness. The observed benefits of PBM in these complex conditions suggest its potential to address pain pathways that are often resistant to conventional therapies. While the mechanisms are still being fully elucidated, the modulation of mitochondrial activity and reduction of inflammation are believed to play key roles in these analgesic effects. The systematic review on PBM in chronic pain included 14 studies, covering populations with fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain. Most trials demonstrated significant pain reduction with PBM, particularly in fibromyalgia and neuropathy. Photobiomodulation in chronic pain: a systematic review of randomized clinical trials provides detailed insights into these findings.

Beyond Pain Relief: Functional Gains and Quality of Life

The benefits of PBM extend beyond mere pain reduction. Several studies within the systematic review also reported improvements in patients' functional abilities and overall quality of life. Chronic pain often severely impacts daily activities, limiting mobility and participation in social or professional life. By reducing pain, PBM can indirectly contribute to better physical function, allowing individuals to perform tasks with greater ease and less discomfort. Improved quality of life is a critical outcome for any chronic condition, reflecting a patient's overall well-being and satisfaction with their health. These secondary outcomes underscore PBM's potential to offer comprehensive support to individuals managing chronic pain, helping them regain a sense of normalcy and improve their daily living experience. The observed functional gains and improved quality of life, alongside pain reduction, highlight PBM's holistic impact on chronic pain management.

Is PBM Safe for Tendon and Other Pain Conditions?

Yes, photobiomodulation (PBM) appears to be a safe therapeutic option for various pain conditions, including those that might affect tendons. The systematic review on chronic pain, which analyzed 14 randomized clinical trials, reported a consistently low incidence of adverse events. This low rate of side effects significantly reinforces PBM's safety profile, making it an attractive non-invasive treatment alternative. While the diversity in technical parameters across different studies can complicate the standardization of results, the overall safety record remains a strong point for PBM.

Low Incidence of Adverse Events

One of the most encouraging aspects of PBM, as highlighted by multiple studies, is its safety. The systematic review focused on chronic pain explicitly stated that the incidence of adverse events associated with PBM was low. This finding is critical for any therapeutic intervention, especially for conditions that require ongoing management. Low-level laser therapy, a form of PBM, has been studied for years, with a consistent record of safety. For patients seeking relief from chronic pain or tendon injuries, knowing that a treatment is unlikely to cause significant side effects can increase confidence and adherence to the therapy. The absence of serious adverse events across numerous trials underscores PBM's potential as a well-tolerated treatment option. This safety aspect is particularly important for conditions like tendon injuries, where invasive procedures carry higher risks.

Comparing PBM Safety with Other Treatments

When considering treatments for chronic pain or musculoskeletal issues, safety is often a primary concern. Many conventional pain management strategies, such as pharmacological interventions, can come with a range of side effects, from mild gastrointestinal issues to more severe systemic complications. In contrast, PBM offers a non-pharmacological, non-invasive alternative that avoids many of these risks. The low incidence of adverse events observed in PBM studies positions it favorably against more aggressive treatments. While PBM may not replace all other therapies, its safety profile makes it a valuable adjunct or primary option, especially for patients who are sensitive to medications or prefer non-drug approaches. The systematic review noted that the incidence of adverse events was low, reinforcing the method's safety. This reinforces PBM's position as a relatively safe intervention.

Challenges in Standardization and Protocol Diversity

Despite its strong safety record, PBM faces challenges regarding the standardization of its application. The systematic review on chronic pain pointed out that the heterogeneity of technical parameters across different trials compromises the standardization of results. This means that factors like the wavelength of light, power density, duration of treatment, number of sessions, and the specific device used can vary significantly from one study to another. For tendon injuries, this variability can make it difficult to establish a universally effective protocol. While the low adverse event rate remains consistent, optimizing PBM for specific conditions requires further research to determine the most effective treatment parameters. Researchers continue to work towards identifying optimal protocols that can maximize therapeutic benefits while maintaining the excellent safety profile PBM has demonstrated. This ongoing effort aims to refine PBM application for conditions like tendonitis, ensuring consistent and reproducible outcomes.

How Does PBM Affect Exercise Performance and Recovery?

Photobiomodulation (PBM) has been investigated for its potential to enhance exercise performance and aid in recovery, but the evidence, particularly for whole-body application, shows mixed results. While localized PBM has been studied as a method to improve exercise outcomes, a systematic review specifically evaluating whole-body PBM found no direct benefits for exercise performance or recovery biomarkers. However, this review did identify some interesting secondary effects, such as improved sleep quality, which can indirectly support recovery.

Whole-Body PBM and Exercise Outcomes

The systematic review on whole-body PBM for exercise performance and recovery included five studies. These studies involved a total of 105 physically active participants, encompassing both sexes and various exercise modalities. The primary objective was to assess whether whole-body PBM, applied before or after exercise, could enhance performance or recovery. The findings from this comprehensive analysis were clear: none of the five identified studies reported any benefit of whole-body PBM on biomarkers of fatigue or exercise performance. This suggests that simply exposing the entire body to red and near-infrared light may not be sufficient to directly improve athletic capabilities or reduce physiological markers of fatigue. This outcome highlights a significant discrepancy compared to some localized PBM studies, which have shown more promising results for specific muscle groups or injury sites.

Impact on Sleep Quality

Despite the lack of direct evidence for improved exercise performance or recovery biomarkers, the systematic review did uncover a notable secondary benefit of whole-body PBM: improved sleep quality. Two out of the five studies reported better sleep quality among participants using whole-body PBM. This improvement was determined through both subjective questionnaires and commercial sleep trackers. Specific objective measures included higher serum melatonin levels and a lower nocturnal heart rate in participants who received whole-body PBM. Sleep is a crucial component of recovery, allowing the body to repair and regenerate. Therefore, while whole-body PBM may not directly impact performance metrics, its potential to enhance sleep could indirectly contribute to better overall recovery. As Mario Álvarez-Martínez et al. stated, "Whole-body PBM may improve sleep quality but shows no evidence of benefits for exercise recovery or performance. Further research is necessary to resolve discrepancies with the benefits observed in localized PBM studies." This quote from A systematic review on whole-body photobiomodulation for exercise performance and recovery summarizes the current understanding of whole-body PBM's role in exercise contexts.

Discrepancies Between Localized and Whole-Body PBM

The review's conclusion points to a critical area for further research: resolving the discrepancies between the observed benefits of localized PBM and the lack of evidence for whole-body PBM in exercise performance and recovery. Localized PBM, which targets specific muscles or injury sites, has been more extensively studied and, in some cases, shown to improve outcomes. The difference in efficacy could stem from several factors, including dosage, penetration depth, and the concentration of light energy at the target tissue. Whole-body application might dilute the therapeutic effect, or the specific parameters required for systemic benefits might be different from those for local effects. Future research needs to explore these differences to understand why localized PBM might offer advantages that whole-body application does not, particularly concerning exercise-related benefits.

What About Fibromyalgia and PBM?

Fibromyalgia is one of the chronic pain conditions where photobiomodulation (PBM) has shown significant promise in reducing pain. Research indicates that PBM, specifically low-level laser therapy (LLLT), can be an effective treatment for this widespread pain disorder. Early studies and more recent meta-analyses have supported its use, highlighting its potential to offer relief to patients who often struggle with conventional therapies. This makes PBM a notable alternative or complementary approach for managing fibromyalgia symptoms.

Early Evidence of Efficacy

The efficacy of low power laser therapy in fibromyalgia was demonstrated in a single-blind, placebo-controlled trial published in 2002. This early study provided foundational evidence that PBM could significantly reduce pain in fibromyalgia patients. Such trials are crucial because they compare the active treatment against a sham or inactive treatment, helping to isolate the true effects of the laser therapy. The positive outcomes from this 2002 study paved the way for further investigation into PBM as a viable treatment for fibromyalgia, encouraging more extensive research into its mechanisms and optimal application protocols. The 2002 study, Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial, served as an important early indicator of PBM's potential.

Systematic Reviews and Meta-Analyses

Building on earlier findings, a systematic review and meta-analysis published in 2019 further evaluated low-level laser therapy for fibromyalgia. This type of comprehensive review pools data from multiple studies, providing a more robust assessment of treatment efficacy. Meta-analyses are particularly valuable because they can identify consistent patterns across different trials, even when individual study designs vary. The 2019 meta-analysis provided a broader perspective on the therapeutic benefits of LLLT for fibromyalgia, reinforcing the earlier findings and contributing to a growing body of evidence supporting its use. This continuous accumulation of evidence through systematic reviews helps clinicians and patients make informed decisions about treatment options. Low-Level Laser Therapy for Fibromyalgia: A Systematic Review and Meta-Analysis provides a thorough analysis of the aggregated data. A clinical trial registered as NCT02948634 on ClinicalTrials.gov also investigated low-level laser therapy in patients with chronic fibromyalgia, indicating ongoing research interest in this area.

PBM's Role in Fibromyalgia Management

Fibromyalgia is characterized by chronic widespread pain, fatigue, sleep disturbances, and cognitive issues. Traditional treatments often involve a combination of medication, exercise, and psychological therapies. PBM offers a non-pharmacological option that can complement these approaches or serve as an alternative for patients who do not respond well to medications. The significant pain reduction observed with PBM, as highlighted in the systematic review on chronic pain, is particularly important for fibromyalgia patients. This condition can severely impact quality of life, and any therapy that offers effective pain relief without significant side effects is highly valuable. The consistent evidence from both individual trials and meta-analyses positions PBM as a promising intervention in the complex management of fibromyalgia.

Can PBM Help with Age-Related Macular Degeneration?

Photobiomodulation (PBM) is currently considered a controversial approach for managing dry age-related macular degeneration (AMD). Despite the debate, the underlying principle of PBM in this context is to modulate mitochondrial activity, aiming to potentially halt or even reverse the progression of vision loss associated with the condition. The efficacy and clinical relevance of PBM for dry AMD remain subjects of ongoing research and discussion within the medical community.

The Controversial Nature of PBM for AMD

Age-related macular degeneration (AMD) is a leading cause of vision loss, particularly in older adults. Dry AMD, the more common form, involves the thinning of the macula and the presence of drusen, which are yellow deposits. PBM's application in AMD is considered controversial because, while theoretically sound—given its ability to enhance cellular function and reduce inflammation—clinical outcomes have not always been uniformly conclusive or widely accepted. The debate centers on whether PBM can truly halt or reverse the disease progression, or if its effects are too subtle to be clinically significant. This ongoing discussion underscores the need for robust, well-designed studies to provide definitive answers regarding its role in AMD management.

Modulating Mitochondrial Activity for Vision

The rationale for using PBM in AMD is rooted in its ability to modulate mitochondrial activity. Mitochondria are often referred to as the "powerhouses" of the cell, producing the energy (ATP) needed for various cellular processes. In conditions like AMD, mitochondrial dysfunction is thought to play a role in the degeneration of retinal cells. By enhancing mitochondrial function, PBM aims to improve the health and survival of these cells, potentially preserving vision. The red and near-infrared light wavelengths used in PBM can penetrate the eye's tissues to reach the retina, where they are absorbed by chromophores in the mitochondria. This absorption is believed to kickstart beneficial cellular responses, including reduced oxidative stress and improved cellular metabolism, which are vital for maintaining retinal health.

Systematic Reviews and Meta-Analyses for AMD

To address the ongoing debate, a systematic review and meta-analysis of randomized clinical trials was specifically conducted to evaluate PBM efficacy in age-related macular degeneration. This comprehensive review, published in August 2024, aimed to provide a clearer picture of PBM's effectiveness and clinical relevance for dry AMD patients. By systematically searching multiple databases for RCTs comparing PBM to sham treatments, researchers sought to synthesize the available evidence. Such meta-analyses are critical for drawing conclusions from a body of research that may contain conflicting individual study results. The findings from this 2024 review will contribute significantly to understanding whether PBM can become a more established treatment option for dry AMD. Photobiomodulation efficacy in age-related macular degeneration: a systematic review and meta-analysis of randomized clinical trials offers the latest insights from this analysis.

Frequently Asked Questions

Is red light therapy effective for all types of pain?

Red light therapy, or photobiomodulation (PBM), has shown effectiveness in reducing chronic pain, particularly in conditions like fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain. A systematic review included 14 randomized clinical trials on PBM for chronic pain, published between September 2015 and September 2025, with most demonstrating significant pain reduction. However, its effectiveness for all types of pain, especially acute or specific injury types, requires further dedicated research.

How quickly can I expect results from PBM for tendon injuries?

The provided research does not specify a timeline for results from PBM for tendon injuries. The systematic review on chronic pain noted that most trials demonstrated significant pain reduction, and some studies observed functional gains and improved quality of life. However, the speed of results can vary depending on the specific condition, individual response, and the PBM protocol used.

Are there any side effects of red light therapy?

The systematic review on photobiomodulation in chronic pain found that the incidence of adverse events was low, reinforcing the method's safety. This suggests that PBM is generally well-tolerated with minimal side effects. However, the heterogeneity of technical parameters across studies means that specific protocols might have varying effects, and individual sensitivities can differ.

Can whole-body PBM improve athletic performance?

Based on a systematic review of whole-body PBM for exercise performance and recovery, none of the five identified studies reported any benefit on biomarkers of fatigue or exercise performance. These studies involved 105 physically active participants. While whole-body PBM may improve sleep quality, it does not currently show evidence of direct benefits for athletic performance.

What is the difference between local and whole-body PBM?

Local PBM involves targeting a specific area of the body with red and near-infrared light, often used for localized pain or injuries. Whole-body PBM involves exposing the entire body to these light wavelengths. While local PBM has been studied for exercise performance and recovery, a systematic review found no evidence of benefits for exercise performance or fatigue biomarkers with whole-body PBM in five identified studies.